Skip to main content
Erschienen in: Reactions Weekly 1/2012

01.05.2012 | Case report

Dabigatran etexilate

Postoperative bleeding in an elderly patient treated with recombinant factor VIIa: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literatur
1.
Zurück zum Zitat Warkentin TE, Margetts P, Connolly SJ, Lamy A, Ricci C, Eikelboom JW.Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding. Blood 119: 2172-2174, No. 9, Mar 2012. Available from: URL: http://dx.doi.org/10.1182/blood-2011-11-393587 - Canada Warkentin TE, Margetts P, Connolly SJ, Lamy A, Ricci C, Eikelboom JW.Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding. Blood 119: 2172-2174, No. 9, Mar 2012. Available from: URL: http://​dx.​doi.​org/​10.​1182/​blood-2011-11-393587 - Canada
Metadaten
Titel
Dabigatran etexilate
Postoperative bleeding in an elderly patient treated with recombinant factor VIIa: case report
Publikationsdatum
01.05.2012
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2012
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201214020-00070

Weitere Artikel der Ausgabe 1/2012

Reactions Weekly 1/2012 Zur Ausgabe

Case report

Various drugs

Case report

Lithium

Case report

Capecitabine

Case report

Romiplostim